Evidence map›Paper›PMID 33039267›Full record

ArticleJournal of infection and chemotherapy : official journal of the Japan Society of Chemotherapy2021

Severe olfactory and gustatory dysfunctions in a Japanese pediatric patient with coronavirus disease (COVID-19).

Yuki Kasuga, Koji Nishimura, Hidetoshi Go, Kimitaka Nakazaki, Shoichi Shimizu, Koji Kanezawa, Makoto Tanaka, Takeshi Oshima, Ichiro Morioka

Open access · bronzeAbstract readCase Reports
In one paragraph

Article in Journal of infection and chemotherapy : official journal of the Japan Society of Chemotherapy, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed, 2 pooled it
0.4field-weighted citation impact, top 42% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed, 2 syntheses or guidelines pooled it, 7 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 1 institution in 1 country.

Yuki KasugaDepartment of Pediatrics and Child Health, Nihon University School of Medicine, Tokyo, Japan.
Koji NishimuraDepartment of Pediatrics and Child Health, Nihon University School of Medicine, Tokyo, Japan.
Hidetoshi GoDepartment of Pediatrics and Child Health, Nihon University School of Medicine, Tokyo, Japan.
Kimitaka NakazakiDepartment of Pediatrics and Child Health, Nihon University School of Medicine, Tokyo, Japan.
Shoichi ShimizuDepartment of Pediatrics and Child Health, Nihon University School of Medicine, Tokyo, Japan.
Koji KanezawaDepartment of Pediatrics and Child Health, Nihon University School of Medicine, Tokyo, Japan.
Makoto TanakaDepartment of Otolaryngology, Head and Neck Surgery, Nihon University School of Medicine, Tokyo, Japan.
Takeshi OshimaDepartment of Otolaryngology, Head and Neck Surgery, Nihon University School of Medicine, Tokyo, Japan.
Ichiro MoriokaDepartment of Pediatrics and Child Health, Nihon University School of Medicine, Tokyo, Japan. Electronic address: morioka.ichiro@nihon-u.ac.jp.
Nihon University · JP

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Coronavirus disease (COVID-19) is often characterized by abnormal olfactory and gustatory symptoms in adults; however, detailed studies on pediatric patients with COVID-19 are extremely limited. A 13-year-old Japanese girl presented with fever and cough, and after 2 days, her olfactory and taste sensations suddenly disappeared. A real-time reverse transcriptase-polymerase chain reaction (RT-PCR) test for severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) was performed using a nasopharyngeal swab. Because a positive result was seen, she was admitted on the 7th day of illness. On admission, the visual analogue scale (VAS) score for smell and taste was 0 of 100%. An intravenous olfaction test using prosultiamine (Alinamin test) was performed on the 15th day of illness to evaluate olfaction, and an increase in latency (33 seconds) and a decrease in duration (55 seconds) were observed. In the odor identification test using 12 different odor cards, only 7 odors were correctly identified. On the 18th day of illness, SARS-CoV-2 tested negative in the RT-PCR test; simultaneously, the VAS score for smell and taste fully improved to 100 of 100%. On the 77th day of illness, full recovery was confirmed in the Alinamin test (latency, 7 seconds; duration, 82 seconds). In this present case, an improvement in olfactory and gustatory dysfunctions was observed with negative results in RT-PCR test for SARS-CoV-2.

Indexed as

AdolescentBetacoronavirusCoronavirus InfectionsCOVID-19FemaleHumansJapanOlfaction DisordersPandemicsPneumonia, ViralReverse Transcriptase Polymerase Chain ReactionSARS-CoV-2SmellTasteTaste DisordersAngiotensin-converting enzyme 2 receptorIntravenous olfaction testReal-time reverse transcriptase-polymerase chain reactionVisual analogue scale

Identifiers

PMID33039267
PMCPMC7526635
OpenAlexW3091668168

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.